Editas Medicine, Inc. (EDIT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Editas Medicine, Inc. (EDIT) Stock Price, News, Quote & History Yahoo! Finance Canada
Editas Medicine (NASDAQ:EDIT) Stock: Insider Linda Burkly Sells 7,814 Shares
Editas Medicine (NASDAQ:EDIT) Stock: Insider Linda Burkly Sells 7,814 Shares MarketBeat
Analyst Rating Updates for Editas Medicine
Financial analysts from RBC Capital and Wells Fargo maintained their respective ratings and price targets for Editas Medicine on November 10, 2026.
Editas Medicine Q3 EPS $(0.15) Beats $(0.18) Estimate, Sales $10.365M Beat $4.460M Estimate
Editas Medicine Q3 EPS $(0.15) Beats $(0.18) Estimate, Sales $10.365M Beat $4.460M Estimate(摘要待生成)
Editas Medicine Reports Third Quarter 2026 Financial Results and Provides Business Updates
Editas Medicine announced its financial results for the third quarter of 2026 and shared positive preclinical data for its EDIT-401 program.
Editas Medicine, 8-K (2.02, 9.01): reported results of operations
Editas reported $190.2 million in cash and securities and a runway into the second half of 2028, progress toward starting its EDIT-401 Phase 1/2 study, and a milestone payment triggered by acceptance of a second Bristol Myers Squibb collaboration IND/CTA.